ロード中...
Delayed Infusion Reactions to Enzyme Replacement Therapies
Background: There are currently ten intravenous enzyme replacement therapy (ERT) products available for the treatment of eight different lysosomal diseases (LD) in the USA. Additional ERT products are in clinical trials. The most common ERT adverse events are infusion reactions (IR). While IR are of...
保存先:
| 出版年: | JIMD Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5509557/ https://ncbi.nlm.nih.gov/pubmed/27557812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2016_8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|